Complication topics

Dysplasia

Articles tagged with Dysplasia in the complications topic, grouped for easier browsing of related complication research and patient-relevant updates.

16 articles

Thymic Lymphoid Follicular Hyperplasia in a Young Woman with Refractory Ulcerative Colitis and Thyroid Autoimmunity: A Case Report and Narrative Review
Quality in Sport

Thymic Lymphoid Follicular Hyperplasia in a Young Woman with Refractory Ulcerative Colitis and Thyroid Autoimmunity: A Case Report and Narrative Review

The case links thymic hyperplasia, thyroid autoimmunity, and severe UC with colorectal neoplasia, suggesting possible shared immune dysregulation that might interest patients and clinicians, but it does not support...

Read Summary
Colonoscopic and histopathological findings in obese patients with fibroscan-detected hepatic steatosis: a cross-sectional study
Egyptian Liver Journal

Colonoscopic and histopathological findings in obese patients with fibroscan-detected hepatic steatosis: a cross-sectional study

Obese patients with FibroScan-detected steatosis in this cohort had a high frequency of colitis and some cases of IBD, dysplasia, and cancer, which could affect screening and symptom evaluation decisions.

Read Summary
Cumulative Local and Metachronous Recurrence Rates in Patients with Ulcerative Colitis-Associated Neoplasia after Endoscopic Submucosal Dissection
Gut and Liver

Cumulative Local and Metachronous Recurrence Rates in Patients with Ulcerative Colitis-Associated Neoplasia after Endoscopic Submucosal Dissection

Findings describe how often and when dysplasia recurs after ESD for UC-associated neoplasia, information that can affect decisions about endoscopic treatment versus colectomy and surveillance planning.

Read Summary
Dioscin activates myeloid AMPK to restore Lgr5⁺ stem cell homeostasis and promote mucosal repair in ulcerative colitis.
Pharmacological research

Dioscin activates myeloid AMPK to restore Lgr5⁺ stem cell homeostasis and promote mucosal repair in ulcerative colitis.

This study suggests a new preclinical approach to help the gut lining heal in ulcerative colitis by targeting macrophage metabolism (myeloid AMPK) rather than directly treating epithelial cells. That could matter for...

Read Summary
Inflammatory bowel disease-associated colorectal dysplasia: the expanding morphologic landscape and diagnostic challenges.
Virchows Archiv : an international journal of pathology

Inflammatory bowel disease-associated colorectal dysplasia: the expanding morphologic landscape and diagnostic challenges.

Accurate recognition and standardized reporting of IBD-associated dysplasia help guide surveillance and surgical decisions because some dysplastic variants are flat, endoscopically invisible, and linked to advanced or...

Read Summary
Basal crypt dysplasia in inflammatory bowel disease: morphological quandaries, p53 immunohistochemistry and diagnostic pointers
Virchows Archiv

Basal crypt dysplasia in inflammatory bowel disease: morphological quandaries, p53 immunohistochemistry and diagnostic pointers

Basal crypt dysplasia is easy to miss but linked to higher risk of advanced colorectal neoplasia in longstanding IBD. Improved recognition and use of p53 immunohistochemistry or complementary biomarkers could affect...

Read Summary
A Solitary Rectal Retention Polyp in an Adult Patient with Ulcerative Colitis: A Case Report
Case Reports in Clinical Practice

A Solitary Rectal Retention Polyp in an Adult Patient with Ulcerative Colitis: A Case Report

Surveillance colonoscopies in IBD are meant to detect dysplasia or cancer; this report shows some solitary polyps may be benign retention polyps. Correct endoscopic removal and pathology spare patients from unnecessary...

Read Summary
Dysbiotic microbiota trigger colitis-associated colorectal cancer and imprint a distinctive bile acid profile in a PSC-IBD model.
Gut

Dysbiotic microbiota trigger colitis-associated colorectal cancer and imprint a distinctive bile acid profile in a PSC-IBD model.

If you have PSC-IBD or care for someone who does, this study suggests the gut microbiota and its ability to make secondary bile acids may help drive inflammation and colorectal dysplasia risk.

Read Summary
Nonconventional Colorectal Dysplasia Is Less Prevalent and Has a More Limited Morphologic Spectrum in Patients Without Inflammatory Bowel Disease.
Human pathology

Nonconventional Colorectal Dysplasia Is Less Prevalent and Has a More Limited Morphologic Spectrum in Patients Without Inflammatory Bowel Disease.

This study helps distinguish patterns of colorectal dysplasia seen in people without IBD from those seen in IBD, which may affect how pathologists and clinicians interpret biopsy findings and consider cancer risk and...

Read Summary
Characterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a Prospective, Observational and Multicenter Study
ClinicalTrials.gov

Characterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a Prospective, Observational and Multicenter Study

The study will prospectively evaluate how often dysplasia occurs, how lesions look and behave after endoscopic resection, and what factors predict local or distant recurrence—information that could change surveillance...

Read Summary
High-grade Dysplasia with Pseudocarcinomatous Invasion Mimicking Invasive Carcinoma in a Patient with Ulcerative Colitis
Journal of Gastrointestinal and Liver Diseases

High-grade Dysplasia with Pseudocarcinomatous Invasion Mimicking Invasive Carcinoma in a Patient with Ulcerative Colitis

People with ulcerative colitis undergo surveillance for dysplasia because of an increased risk of colorectal cancer. This case highlights a pathology pattern (pseudocarcinomatous invasion) that can mimic invasive...

Read Summary
Potential role of PPARGC1A in linking ulcerative colitis to colorectal cancer: a novel prognostic biomarker and therapeutic target.
Translational cancer research

Potential role of PPARGC1A in linking ulcerative colitis to colorectal cancer: a novel prognostic biomarker and therapeutic target.

People with long-standing ulcerative colitis face an increased risk of colorectal cancer; this study highlights PPARGC1A as a gene that may be downregulated early in that progression, which could eventually help identify...

Read Summary